CH EPL (R5)
1.0.1 - trial-use Switzerland flag

This page is part of the CH EPL (R5) (v1.0.1: DSTU 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version. For a full list of available versions, see the Directory of published versions

Example RegulatedAuthorization: 67719001

identifier: Marketing Authorisation Number/67719001

subject: PackagedProductDefinition: identifier = http://fhir.ch/ig/ch-epl/sid/pcid#Clinical Product Identifier#CH-01100726-0677190010000-0001; containedItemQuantity = 72 Tablet; description = CUPRIOR Filmtabl 150 mg 72 Stk

type: Marketing Authorisation

region: Switzerland

status: valid

statusDate: 2021-01-21

holder: Organization Curatis AG

regulator: Organization Swissmedic Swiss Agency for Therapeutic Products

Generated Narrative: Organization #holder-Curatis-AG

Profile: Organization

identifier: Swissmedic Location Identifier/01100726, LOC Identifier/100082791, GLN Identifier/7640109110007

name: Curatis AG

Generated Narrative: Organization #regulator-SMC

Profile: Organization

identifier: LOC Identifier/100010911, GLN Identifier/7601001398511

name: Swissmedic Swiss Agency for Therapeutic Products